Basking Ridge, NJ, United States of America

Jungchul Kim

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Werthenstein Biopharma Gmbh. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jungchul Kim. Retrieved from https://idiyas.com/inventor/jungchul-kim-di5mk88c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jungchul Kim

Introduction

Jungchul Kim is a notable inventor based in Basking Ridge, NJ, with a significant contribution to the field of pharmaceuticals. He holds three patents that showcase his expertise in developing innovative processes and compounds. His work primarily focuses on creating intermediates for drug synthesis, particularly in the area of cancer treatment.

Latest Patents

One of Jungchul Kim's latest patents is titled "Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide." This invention relates to the preparation of protected piperidine carboxylates, which serve as intermediates leading to the development of a beta-lactamase inhibitor. Another significant patent is "Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates." This disclosure provides crystalline forms for certain synthetic intermediates used in the production of belzutifan, a HIF-2α inhibitor beneficial for cancer treatment.

Career Highlights

Throughout his career, Jungchul Kim has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH, where he has contributed to various innovative projects and research initiatives.

Collaborations

Jungchul Kim has collaborated with esteemed colleagues, including John Y L Chung and Tetsuji Itoh. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Jungchul Kim's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of critical treatments for diseases such as cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…